Vilanterol Trifenate

Size	Price	Stock	Quantity
Get Quotation Now Add to Cart Bulk Inquiry

Shipping and handling fee USD40, Free delivery is qualified when the total value of your order exceeds USD500.If the item is temporarily out of stock. Please email to order@pharm-intermediates.com,we will inform you when we have it in stock.

Chemical Information

Product name：Vilanterol Trifenate	Purity：99% min
CAS NO：503070-58-4	Solubility：DMSO : 100 mg/mL (129.07 mM)
Molecular Formula：C₄₄H₄₉Cl₂NO₇	Package：Package according to customer requirements
Molecular Weight：774.768	Storage：Store at -20℃

Quality control

Remarks

Vilanterol, also known as GW-642444, is a long-acting beta-2 agonist drug, which in May 2013 was approved in combination with fluticasone furoate for sale as Breo Ellipta by GlaxoSmithKline for the treatment of chronic obstructive pulmonary disease (COPD).

Vilanterol Trifenatate is a long-acting β2 adrenergic receptor Agonist. It demonstrates prolonged bronchodilation in subjects with asthma and COPD.

Adrenergic Receptor Inhibitors Related Products:

Nebivolol hydrochloride; Nebivolol; Betaxolol; Betaxolol HCl; Doxazosin Mesylate; Alfuzosin HCl; Silodosin; Prazosin Hydrochloride; Terazosin hydrochloride dihydrate; Sotalol hydrochloride; Dapiprazole Hydrochloride; Cisatracurium besylate; Ivabradine hydrochloride

References

[1]. Slack RJ, et al. In vitro pharmacological characterization of vilanterol, a novel long-acting β2-adrenoceptor agonist with 24-hour duration of action. J Pharmacol Exp Ther. 2013 Jan;344(1):218-30

[2]. Kempsford R, et al. Vilanterol trifenatate, a novel inhaled long-acting beta2 adrenoceptor agonist, is well tolerated in healthy subjects and demonstrates prolonged bronchodilation in subjects with asthma and COPD. Pulm Pharmacol Ther. 2013 Apr;26(2):256-